Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Harnblase: Tumorvorstufen und nichtinvasive Karzinome (2024) Lange F, Hartmann A, Eckstein M Journal article AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024) Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al. Journal article The impact of the tumor microenvironment on the survival of penile cancer patients. (2024) Lohse S, Mink JN, Eckhart L, Hans MC, Jusufi L, Zwick A, Mohr T, et al. Journal article Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) in Penile Squamous Cell Carcinoma-No Evidence for a Role in Carcinogenesis. (2024) Fiegl A, Wendler O, Giedl J, Gaisa NT, Richter G, Campean V, Burger M, et al. Journal article Tumor-in-tumor metastasis: a rare phenomenon Tumor-in-Tumor-Metastase: Ein seltenes Phänomen (2024) Elsner F, Keller K, Fuchs F, Uder M, Hartmann A Journal article High interobserver variability of PTEN immunohistochemistry defining PTEN status in low- to intermediate-risk prostate cancer: results of the first German ring trial (2024) Hommerding O, Bernhardt M, Kreft T, Scherping A, Abbas M, Baretton G, Bräsen JH, et al. Journal article Discrimination between Inflammatory and Fibrotic Activity in Crohn's Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging (2024) Beck M, Kuwert T, Atzinger A, Gerner M, Hartmann A, Saake M, Uder M, et al. Journal article Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023) Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al. Journal article Explainable convolutional neural networks for assessing head and neck cancer histopathology (2023) Dörrich M, Hecht M, Fietkau R, Hartmann A, Iro H, Gostian AO, Eckstein M, Kist A Journal article Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) (2023) Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, Wirtz RM, et al. Journal article